Hello everyone
Question from a worried son with a mother diagnoses with ppc stage 4 due to BRCA2 . She has completed chemo and surgery with good results. She first underwent 3 chemos, then surgery and 3 more chemocures. No visible cancer or cancercells in the omentum after sugery and the lastest CA-125 was 7.
After the last of 6 chemocures the 27th of november, she started up with Avastin/Bevacizumab. Last week she had to end the Avastin treatment due to high protein leves in her urine, so as of now she is not receiving any treatment.
A few weeks ago we learned about Lynparza/Olabarib, and the drug is currently in the approvement process here in Norway for my mothers diagnose. We have talked to several specialists and have received about just as many different advises. One advices us to delay the use of Olabarib until recurrence, one tells us Olabarib only works if you start it up no later than 10-12 weeks after last chemo. The third one is an independent private practitioner, and his advise is to start Olabarib right away. And the reason is her BRCA2 mutation and the effects of Olabarib in BRACA2 patients.
So, there we are. My mother is doing really well and she is back to her old self, working and worrying about us kids We, on the other side, are very avare of the probability of recurrence, and want to make sure she get´s the best treatment possible at her stage.
I´m hoping maybe anyone of you wonderfull people in here might be able to give us some good advice regarding the use of Lynparza/Olaparib at this stage. My worry is that without any treatment, the cancer will return quicker, but on the other side I´m worried about "using up" Lynparza now if the cancer will recure anyhow.
Thank you for reading my post. Any advice or reply is very appreciated.
Kind Regards
Kai